伊里索立通过抑制炎症反应来改善环胺诱导的POI
Mingjin Li1, Zhenhong Wei2, Xiaohong Chen1
1Department of Gynecology and Obstetrics, Gansu Provincial Hospital & The Third Hospital of Lanzhou University, 730000 Lanzhou, Gansu, China.
Frontiers in bioscience (Landmark edition)
|December 6, 2025
概括
伊里索利通过减少卵巢炎症,有效治疗化疗诱导的过早卵巢衰竭 (POI). 这项研究确定伊里索利作为改善POI患者生育能力的有希望的治疗剂.
科学领域:
- 生殖生物学 生殖生物学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 过早卵巢衰竭 (POI) 是循环胺 (CTX) 化疗的显著副作用,导致不孕.
- CTX诱导的卵巢炎症是毛囊细胞损伤和生育能力丧失的关键因素.
- 了解CTX诱导的卵巢炎症的机制对于开发有效的治疗方法至关重要.
研究的目的:
- 阐明CTX诱导的卵巢炎症背后的分子机制.
- 确定潜在的治疗剂,以减轻CTX诱导的POI.
- 在POI的小鼠模型中评估Irisolidone的疗效和机制.
主要方法:
- 用RNA测序和生物信息学分析 (GO,PPI) 来识别CTX诱导的卵巢炎症中的关键基因.
- 传统中医药系统药理数据库和分析平台 (TCMSP) 进行了候选药物的选.
- 建立了一个CTX诱导的小鼠模型,以验证伊里索利的治疗效果.
主要成果:
- 干白素1β (IL1β) 被确定为CTX诱导的卵巢炎症中的核心基因.
- 伊里索利被确定为一种潜在的治疗剂,可显著改善POI小鼠的生育能力.
- 伊里索利通过抑制NFκB/NLRP3/Caspase1信号通路来抑制卵巢炎症.
结论:
- 伊里索立通过向异常的卵巢炎症,有效地减轻CTX诱导的POI.
- 伊里索立显示出作为POI的新型治疗候选药物的潜力.
- 这些发现为化学疗法诱导的不孕症的临床管理提供了新的治疗策略.
相关概念视频
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
461
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
461
01:30Hormonal Control of the Ovarian Cycle
6.3K
The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle. At puberty, GnRH secretion increases in both frequency and...
6.3K
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
413
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
413
02:07Oogenesis
68.8K
In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
68.8K
01:21Drugs for Treatment of Constipation-Predominant IBS
680
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
680
01:17Drugs for Treatment of Diarrhea-Predominant IBS
599
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
599